Sandostatin and malignant neoplasm progression Patient Reports February 11, 2012

Sandostatin Side Effects Report #4623735-4
Sandostatin side effect was reported by a Physician from on Feb 25, 2005. Male patient, 55 years of age, weighting 110.2 lb, was diagnosed with intestinal obstruction, nausea , hypokalaemia, pain , diabetes mellitus and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: colon cancer recurrent, dysuria, malignant neoplasm progression, neurogenic bladder, urinary retention. Sandostatin dosage: unknown. During the same period patient was treated with DECADRON, GASMOTIN, NAUZELIN, PRIMPERAN, SERENACE, POTASSIUM CHLORIDE, DUROTEP JANSSEN, HUMULIN R. Patient was hospitalized. Patient died on 03/14/2005.

Sandostatin Side Effects Report #5042443-1
Sandostatin side effect was reported by a Consumer or non-health professional from JAPAN on June 28, 2006. Female patient, weighting 44.09 lb, was diagnosed with intestinal obstruction and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, thirst. Sandostatin dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE. Patient died.

Sandostatin Side Effects Report #5047376-2
Sandostatin side effect was reported by a Consumer or non-health professional from JAPAN on June 28, 2006. Female patient, weighting 44.09 lb, was diagnosed with intestinal obstruction and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, thirst. Sandostatin dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE. Patient died.

Sandostatin Side Effects Report #5073164-7
Sandostatin side effect was reported by a Physician from JAPAN on Dec 15, 2004. Male patient, 62 years of age, weighting 101.4 lb, was diagnosed with ileus and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal cavity drainage, abdominal pain , abnormal faeces, ascites, malignant neoplasm progression, peritonitis. Sandostatin dosage: unknown. During the same period patient was treated with TAXOL. Patient died on 01/12/2005.


Sandostatin Side Effects Report #4626424-5
Sandostatin side effect was reported by a Physician from on Sept 30, 2003. Male patient, 43 years of age, was diagnosed with hepatic neoplasm malignant non-resectable and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: cerebral ischaemia, cerebrovascular accident, convulsion, embolism, malignant neoplasm progression, thrombosis. Sandostatin dosage: unknown. Patient died on 08/12/2003.

Sandostatin Side Effects Report #5825942-1
Sandostatin side effect was reported by a Pharmacist from JAPAN on July 22, 2008. Female patient, 77 years of age, was diagnosed with gastrointestinal obstruction, abdominal distension and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: hypercapnia, hyperglycaemia, malignant neoplasm progression. Sandostatin dosage: unknown. During the same period patient was treated with NEOPHYLLIN, SILECE, MORPHINE ELIXIR, RED BLOOD CELLS. Patient was hospitalized. Patient died on 07/11/2008.

Sandostatin Side Effects Report #5339739-2
Sandostatin side effect was reported by a Physician from JAPAN on May 25, 2007. Male patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: hepatic failure, malignant neoplasm progression, metastases to liver. Sandostatin dosage: 30MG MONTHLY. During the same period patient was treated with TAKEPRON, SUCRALFATE, ZYRTEC, MEXITIL. Patient died on 04/04/2007.

Sandostatin Side Effects Report #5374357-1
Sandostatin side effect was reported by a Physician from JAPAN on June 26, 2007. Male patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: hepatic failure, malignant neoplasm progression, metastases to liver. Sandostatin dosage: 30MG MONTHLY. During the same period patient was treated with TAKEPRON, SUCRALFATE, ZYRTEC, MEXITIL. Patient died on 04/04/2007.

Sandostatin Side Effects Report #4572453-X
Sandostatin side effect was reported by a Consumer or non-health professional from on Jan 31, 2005. Female patient was diagnosed with gastric outlet obstruction and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: aptyalism, malignant neoplasm progression, ovarian cancer, thirst. Sandostatin dosage: unknown. Patient died on 01/30/2005.


Sandostatin Side Effects Report #5527484-X
Sandostatin side effect was reported by a Pharmacist from UNITED KINGDOM on Nov 23, 2007. Female patient, 44 years of age, was diagnosed with fistula discharge, pain , nausea , prophylaxis against gastrointestinal ulcer, lower respiratory tract infection and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: addison's disease , hyperkalaemia, hyponatraemia, malignant neoplasm progression, renal failure. Sandostatin dosage: unknown. During the same period patient was treated with DIAMORPHINE, CYCLIZINE, OMEPRAZOLE, FENTANYL, LOPERAMIDE, DEXAMETHASONE, PARACETAMOL, CEFACLOR. Patient died on 11/14/2007.

Sandostatin Side Effects Report #5967672-1
Sandostatin side effect was reported by a Health Professional from UNITED STATES on Nov 19, 2008. Male patient was diagnosed with carcinoid tumour of the small bowel, diarrhoea, oedema peripheral and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: cardiac murmur, diarrhoea, dyspnoea exertional, fatigue, hepatomegaly, malignant neoplasm progression, oedema peripheral, portal vein thrombosis, pulse waveform abnormal. Sandostatin dosage: 60 MG, EVERY 4WEEKS. During the same period patient was treated with LOMOTIL, LASIX. Patient died.

Sandostatin Side Effects Report #5411779-4
Sandostatin side effect was reported by a Physician from CANADA on July 31, 2007. Male patient, 67 years of age, was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal pain , cardiac disorder, colostomy, delirium, intestinal anastomosis, intubation, malignant neoplasm progression, malignant tumour excision, obstruction. Sandostatin dosage: 30MG EVERY 4 WEEKS. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5683954-5
Sandostatin side effect was reported by a Physician from BELGIUM on Mar 20, 2008. Male patient, 64 years of age, weighting 116.8 lb, was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, malignant neoplasm progression, performance status decreased. Sandostatin dosage: unknown. Patient was hospitalized. Patient died on 02/17/2008.

Sandostatin Side Effects Report #5634533-7
Sandostatin side effect was reported by a Physician from GERMANY on Feb 13, 2008. Male patient, 59 years of age, weighting 178.6 lb, was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , malignant neoplasm progression, peritoneal mesothelioma malignant, pneumonia , subileus, vomiting. Sandostatin dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR. Patient was hospitalized and became disabled. Patient recovered.


Sandostatin Side Effects Report #5675744-4
Sandostatin side effect was reported by a Physician from GERMANY on Mar 14, 2008. Male patient, 59 years of age, weighting 178.6 lb, was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , malignant neoplasm progression, peritoneal mesothelioma malignant, pneumonia , subileus, vomiting. Sandostatin dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR. Patient was hospitalized and became disabled. Patient recovered.

Sandostatin Side Effects Report #5979384-9
Sandostatin side effect was reported by a Physician from GERMANY on Nov 27, 2008. Male patient, weighting 178.6 lb, was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , malignant neoplasm progression, peritoneal mesothelioma malignant, pneumonia , subileus, vomiting. Sandostatin dosage: 30 MG, UNK. During the same period patient was treated with SANDOSTATIN LAR. Patient was hospitalized and became disabled. Patient recovered.

Sandostatin Side Effects Report #5338057-6
Sandostatin side effect was reported by a Physician from UNITED STATES on May 21, 2007. Male patient, 76 years of age, was diagnosed with carcinoid syndrome, atrial fibrillation , hypertension, hyperlipidaemia and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: condition aggravated, dehydration, diarrhoea, discomfort, dizziness , flushing, malignant neoplasm progression, surgery . Sandostatin dosage: 0.3 ML, BID. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, COUMADIN, TOPROL, DIGITEK, LIPITOR. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #4944711-8
Sandostatin side effect was reported by a Health Professional from UNITED STATES on July 21, 2005. Male patient, 71 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to liver. Sandostatin dosage: 20 MG, QMO, INJECTION NOS; 30 MG, INJECTION NOS; 50 MG, QMO, INJECTION NOS. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, FLUOROURACIL, POTASSIUM, ALDACTAZIDE, ALDORIL, CELEBREX, CLARITIN. Patient died on 04/11/2003.

Sandostatin Side Effects Report #4944960-9
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2005. Male patient, 56 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: diarrhoea, flushing, malignant neoplasm progression, surgery . Sandostatin dosage: 60 MG, QMO. Patient recovered.


Sandostatin Side Effects Report #5157155-3
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Female patient was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: anaphylactic reaction, malignant neoplasm progression, oophorectomy, surgery . Sandostatin dosage: 30 MG, QW. Patient recovered.

Sandostatin Side Effects Report #5454465-7
Sandostatin side effect was reported by a Consumer or non-health professional from ISRAEL on Sept 10, 2007. Female patient was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: ascites, dyspnoea, malignant neoplasm progression. Sandostatin dosage: 30 MG, QMO. Patient was hospitalized. Patient recovered.